We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

How Viral Enzymes Seize Control of Host Genes

By LabMedica International staff writers
Posted on 27 Aug 2008
Researchers have identified a viral mechanism that suppresses expression of host genes and coordinates production of viral proteins. They speculate that this mechanism could be adapted for gene therapy for a variety of human illnesses.

Investigators at Mount Sinai School of Medicine (New York, NY, USA) worked with a virus called PBCV-1 (Paramecium bursaria chlorella virus-1). They were interested in determining whether the virus was able to modify host histones directly to interfere with chromatin-based transcription.

They reported in the August 17, 2008, online edition of the journal Nature Cell Biology that the virus particle contained a methyltransferase enzyme that was packaged with a nuclear localization signal in a complex called vSET. Furthermore, vSET was found to repress gene transcription by direct modification of chromatin.

The investigators speculated that the vSET system could be adapted for use in gene therapy for human diseases. Senior author Dr. Ming-Ming Zhou, professor of structural and chemical biology at Mount Sinai School of Medicine, said, "By being able to silence certain genes, we may be able to suppress genes that can cause diseases such as HIV/AIDS, cancer, inflammation, and diseases of the central and peripheral nervous systems. We now know we can focus on these genes and potentially change the ultimate course of many diseases that have a major impact on people's lives.”

Related Links:
Mount Sinai School of Medicine


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Alzheimer's Disease Biomarker Assay
Elecsys Phospho-Tau (217P) Plasma
Automatic CLIA Analyzer
Shine i6000

Latest BioResearch News

Circulating Tumor DNA Helps Identify Targets for Personalized Immunotherapy
27 Aug 2008  |   BioResearch

Researchers Classify 108 Lysosomal Disorders in Updated Diagnostic Framework
27 Aug 2008  |   BioResearch

New Autoantibody Target Identified in Neuromyelitis Optica Spectrum Disorder
27 Aug 2008  |   BioResearch